Kim Chisholm has extensive experience in the pharmaceutical and financial advisory industries. Currently serving as Associate Vice President for US Alzheimer's Disease Marketing at Eli Lilly and Company since June 2018, Kim Chisholm has held various leadership roles, including General Manager, COO of the Neuroscience Business Unit, and positions in Oncology Strategy & Operations and Diabetes Business Unit sales management. Prior experience includes serving as Vice President at AlixPartners, where Kim Chisholm focused on financial advisory services, and consulting at Deloitte. Academically, Kim Chisholm holds an MBA from Harvard Business School and both a Bachelor of Business Administration in Accounting and a Master of Science in Accountancy from the University of Notre Dame's Mendoza College of Business.
This person is not in any teams
This person is not in any offices